Erythropoietin levels and androgens use: What is their relationship in the correction of anemia?

Archives of Internal Medicine

Volumn 167, Issue 3, 2007, Pages 309-

  Diskin, Charles J ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

ANDROGEN THERAPY; ANEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIESIS; HEMATOCRIT; HUMAN; KIDNEY FAILURE; LETTER; PRIORITY JOURNAL; PROTEIN DETERMINATION;

AGE FACTORS; ANDROGENS; ANEMIA; ERYTHROPOIETIN; HUMANS; KIDNEY FAILURE, CHRONIC; MALE;

EID: 33846941936     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.3.309     Document Type: Letter

References (5)

1. Daniell HW. Erythropoietin resistance during androgen deficiency [letter]. Arch Intern Med. 2006;166:1923.
2. Spivak JL. Erythropoietin resistance during androgen deficiency [reply]. Arch Intern Med. 2006;166:1923-1924.
3. Diskin CJ, Jones KLO, Mora EC. Erythropoietin levels in ESRD by enzyme immunoassay. In: Abstracts of the 17th Meeting of the American Society of Nephrology; December 9-12, 1984; Washington, DC. ASN abstract P.62.
4. Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB. Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients? Nephrology (Carlton). 2006;11:394-399.
5. Eleftheradis T, Liakopoulis V, Kartsios C. Does hepcidin affect erythropoiesis in hemodialysis patients? In: Abstracts of the XLIII Congress of the European Renal Association-European Dialysis and Transplant Association; July 15-18, 2006; Glasgow, Scotland. Abstract P.iv159.